Citi Reiterates Neutral Rating on Alnylam Pharmaceuticals (ALNY)
Go back to Citi Reiterates Neutral Rating on Alnylam Pharmaceuticals (ALNY)| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 219.72 -11.46 (4.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $231.18 | 52 Week High | $109.10 | |||
| Open | $231.31 | 52 Week Low | $31.38 | |||
| Day High | $231.36 | P/E | N/A | |||
| Day Low | $219.40 | EPS | $-1.45 | |||
| Volume | 1,662,498 | |||||
